FiercePharma

The World's Only Transdermal Dopamin Agonist, Neupro® Patch, Approved in Japan for Both Parkinson's Disease and Restless Legs Syndrome

The World's Only Transdermal Dopamin Agonist, Neupro® Patch, Approved in Japan for Both Parkinson's Disease and Restless Legs Syndrome The only transdermal dopamine agonist*1 system, which helps ...
FiercePharma

New data showed sustained 5-year benefit of Neupro® (rotigotine) on symptoms of Restless Legs Syndrome

Latest safety and efficacy results for rotigotine in the treatment of moderate to severe restless legs syndrome presented at major North American neurology congress Brussels (Belgium), 13 April 2010, ...
FierceBiotech

Neupro(R) Filed with the FDA for the Treatment of Restless Legs Syndrome

ATLANTA, Dec. 13 /PRNewswire/ -- UCB announced today that the supplemental New Drug Application (sNDA) for the use of Neupro(R) as a treatment for moderate-to-severe restless legs syndrome (RLS) has ...
FierceBiotech

Press Release: FDA Approves Schwarz Pharma's Neupro for the Treatment of Early-Stage Parkinson's Disease in the U.S.

FDA Approves Schwarz Pharma's Neupro for the Treatment of Early-Stage Parkinson's Disease in the U.S. MONHEIM, Germany, May 10 -- SCHWARZ PHARMA announced today that the U.S. Food and Drug ...
Healthline

Neupro Interactions: Alcohol, Medications, and Others

Neupro (rotigotine) is a prescription skin patch used to treat Parkinson’s disease and restless legs syndrome in adults. Neupro has interactions with other drugs and alcohol. For example, it can ...